Document is current
Any future updates will be listed below
-
Authors
Stenson, Erin K.
Kendrick, Jessica
Dixon, Bradley
Thurman, Joshua M.
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD047349)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076690, R01DK125823, R01DK130255, R01DK130255)
- License Information
-
More Information
Article History
Received: 15 April 2022
Revised: 8 August 2022
Accepted: 9 September 2022
First Online: 6 October 2022
Declarations
:
: Dr. Stenson and Dr. Kendrick declare they have no financial interests. Dr. Dixon is a consultant for Apellis and Alexion Pharmaceuticals, Inc. Dr. Thurman received royalties from Alexion Pharmaceuticals, Inc. and is a consultant for Q32 Bio, Inc., a company developing complement inhibitors. He also holds stock and will receive royalty income from Q32 Bio, Inc.
